Tags

Type your tag names separated by a space and hit enter

Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.

Abstract

Women experience a high prevalence of mood and anxiety disorders, and comorbidity of mood and anxiety disorders is highly prevalent. Both mood and anxiety disorders disturb sleep, attention and, thereby, cognitive function. They result in a variety of somatic complaints. The mood disorder continuum includes minor depression, dysthymia, major depression and bipolar disorder. Chronobiological disorders, such as seasonal affective disorder as well as premenstrual dysphoric disorder, occur in some women, with comorbid seasonal affective disorder and premenstrual dysphoric disorder in just under half of these individuals [1] . Early life experience, heritability, gender, other psychiatric illness, stress and trauma all interact dynamically in the development of mood and anxiety disorders. The epidemiology, nomenclature and clinical diagnostic issues of these illnesses in midlife woman are reviewed.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Kaiser Permanente Northern California, Psychiatry Women's Health Program, Oakland, CA, USA. jeanne@afwh.org

    , ,

    Source

    Expert review of neurotherapeutics 7:11 Suppl 2007 Nov pg S45-58

    MeSH

    Anxiety Disorders
    Comorbidity
    Female
    Humans
    Mood Disorders
    Sex Factors
    Terminology as Topic

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't
    Review

    Language

    eng

    PubMed ID

    18039068

    Citation

    Alexander, Jeanne Leventhal, et al. "Women, Anxiety and Mood: a Review of Nomenclature, Comorbidity and Epidemiology." Expert Review of Neurotherapeutics, vol. 7, no. 11 Suppl, 2007, pp. S45-58.
    Alexander JL, Dennerstein L, Kotz K, et al. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology. Expert Rev Neurother. 2007;7(11 Suppl):S45-58.
    Alexander, J. L., Dennerstein, L., Kotz, K., & Richardson, G. (2007). Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology. Expert Review of Neurotherapeutics, 7(11 Suppl), pp. S45-58.
    Alexander JL, et al. Women, Anxiety and Mood: a Review of Nomenclature, Comorbidity and Epidemiology. Expert Rev Neurother. 2007;7(11 Suppl):S45-58. PubMed PMID: 18039068.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology. AU - Alexander,Jeanne Leventhal, AU - Dennerstein,Lorraine, AU - Kotz,Krista, AU - Richardson,Gregg, PY - 2007/12/6/pubmed PY - 2008/2/29/medline PY - 2007/12/6/entrez SP - S45 EP - 58 JF - Expert review of neurotherapeutics JO - Expert Rev Neurother VL - 7 IS - 11 Suppl N2 - Women experience a high prevalence of mood and anxiety disorders, and comorbidity of mood and anxiety disorders is highly prevalent. Both mood and anxiety disorders disturb sleep, attention and, thereby, cognitive function. They result in a variety of somatic complaints. The mood disorder continuum includes minor depression, dysthymia, major depression and bipolar disorder. Chronobiological disorders, such as seasonal affective disorder as well as premenstrual dysphoric disorder, occur in some women, with comorbid seasonal affective disorder and premenstrual dysphoric disorder in just under half of these individuals [1] . Early life experience, heritability, gender, other psychiatric illness, stress and trauma all interact dynamically in the development of mood and anxiety disorders. The epidemiology, nomenclature and clinical diagnostic issues of these illnesses in midlife woman are reviewed. SN - 1744-8360 UR - https://www.unboundmedicine.com/medline/citation/18039068/Women_anxiety_and_mood:_a_review_of_nomenclature_comorbidity_and_epidemiology_ L2 - http://www.tandfonline.com/doi/full/10.1586/14737175.7.11s.S45 DB - PRIME DP - Unbound Medicine ER -